Get started
Zydus Lifesciences LimitedZydus Lifesciences LimitedZydus Lifesciences Limited

Zydus Lifesciences Limited

No trades
No trades
OverviewFinancialsNewsDocumentsCommunityTechnicalsForecastsSeasonalsOptionsBondsETFs
Full chart
Full chart

Compare with Zydus Lifesciences Limited



Key stats


Market capitalization
‪1.15 T‬ INR
Dividend yield (indicated)
0.09%
Price to earnings Ratio (TTM)
23.15
Basic EPS (TTM)
50.10 INR
Net income (FY)
‪50.40 B‬ INR
Revenue (FY)
‪270.25 B‬ INR
Shares float
‪247.75 M‬
Beta (1Y)
0.46

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Employees


Employees (FY)
‪36.83 K‬
Change (1Y)
‪+8.91 K‬+31.92%
Revenue / Employee (1Y)
‪7.34 M‬ INR
Net income / Employee (1Y)
‪1.37 M‬ INR

Profile


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Sharvil Pankajbhai Patel
Website
zyduscadila.com
Headquarters
Ahmedabad
Founded
1952
IPO date
May 15, 1995
ISIN
INE010B01027
FIGI
BBG000CM2DT5
Identifiers
ISIN INE010B01027
CFI code
ESVUFN
Zydus Lifesciences Ltd. engages in the discovery, development, and manufacture of pharmaceutical products under Zydus brand. The firm's products portfolio includes active pharmaceutical ingredients, human formulations, and animal health & veterinary. It operates through the following segments: Pharmaceuticals and Consumer Products. The Pharmaceuticals segment represents the business of integrated pharmaceutical operations with business encompassing the entire value chain in the research, development, production, marketing and distribution of pharmaceutical products. The Consumer Products segment represents the business of development, production, marketing, and distribution of differentiated health and wellness products. The company was founded by Ramanbhai B. Patel in 1952 and is headquartered in Ahmedabad, India.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Highest yielding bonds


— YTM
Maturity dateSep 1, 2027
Coupon6.50% (Fixed)

See all ZYDUSLIFE bonds 

Frequently asked questions


The current price of ZYDUSLIFE is 1,150.80 INR — it has decreased by −0.71% in the past 24 hours. Watch Zydus Lifesciences Limited stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange Zydus Lifesciences Limited stocks are traded under the ticker ZYDUSLIFE.
ZYDUSLIFE stock has risen by 4.14% compared to the previous week, the month change is a 3.72% rise, over the last year Zydus Lifesciences Limited has showed a 17.61% increase.
We've gathered analysts' opinions on Zydus Lifesciences Limited future price: according to them, ZYDUSLIFE price has a max estimate of 1,457.00 INR and a min estimate of 800.00 INR. Watch ZYDUSLIFE chart and read a more detailed Zydus Lifesciences Limited stock forecast: see what analysts think of Zydus Lifesciences Limited and suggest that you do with its stocks.
ZYDUSLIFE reached its all-time high on Aug 9, 2024 with the price of 1,324.30 INR, and its all-time low was 5.15 INR and was reached on Jul 25, 2001. View more price dynamics on ZYDUSLIFE chart.
See other stocks reaching their highest and lowest prices.
ZYDUSLIFE stock is 1.74% volatile and has beta coefficient of 0.46. Track Zydus Lifesciences Limited stock price on the chart and check out the list of the most volatile stocks — is Zydus Lifesciences Limited there?
Today Zydus Lifesciences Limited has the market capitalization of ‪1.15 T‬, it has increased by 0.67% over the last week.
Yes, you can track Zydus Lifesciences Limited financials in yearly and quarterly reports right on TradingView.
Zydus Lifesciences Limited is going to release the next earnings report on Aug 12, 2026. Keep track of upcoming events with our Earnings Calendar.
ZYDUSLIFE earnings for the last quarter are 10.85 INR per share, whereas the estimation was 9.36 INR resulting in a 15.96% surprise. The estimated earnings for the next quarter are 11.23 INR per share. See more details about Zydus Lifesciences Limited earnings.
Zydus Lifesciences Limited revenue for the last quarter amounts to ‪75.87 B‬ INR, despite the estimated figure of ‪70.08 B‬ INR. In the next quarter, revenue is expected to reach ‪76.70 B‬ INR.
ZYDUSLIFE net income for the last quarter is ‪12.72 B‬ INR, while the quarter before that showed ‪10.42 B‬ INR of net income which accounts for 0.00% change. Track more Zydus Lifesciences Limited financial stats to get the full picture.
Yes, ZYDUSLIFE dividends are paid annually. The last dividend per share was 11.00 INR. As of today, Dividend Yield (TTM)% is 0.96%. Tracking Zydus Lifesciences Limited dividends might help you take more informed decisions.
Zydus Lifesciences Limited dividend yield was 0.11% in 2025, and payout ratio reached 2.00%. The year before the numbers were 1.24% and 24.46% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Jul 13, 2026, the company has ‪36.83 K‬ employees. See our rating of the largest employees — is Zydus Lifesciences Limited on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Zydus Lifesciences Limited EBITDA is ‪71.95 B‬ INR, and current EBITDA margin is 26.62%. See more stats in Zydus Lifesciences Limited financial statements.
Like other stocks, ZYDUSLIFE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Zydus Lifesciences Limited stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Zydus Lifesciences Limited technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Zydus Lifesciences Limited stock shows the strong buy signal. See more of Zydus Lifesciences Limited technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.